Protein aggregation has attracted substantial interest because of its role in causing many serious illnesses, such as neurodegenerative diseases and type II diabetes. Recent studies have shown that protein aggregation can be prevented by forming metal ion complexes with a target protein, which affects their conformation in solution and their physical properties, such as aggregation. Thus, understanding the interactions between aggregating molecules and bioactive metal ions such as Cu 2+ is beneficial for new drug discovery. Pramlintide, a synthetic peptide drug, and its natural counterpart rat amylin are known to be resistant to aggregation because of the presence of proline residues, which are usually β-sheet "breakers" within their amino acid sequence. Here, we investigate the Cu 2+ coordination properties of pramlintide and rat amylin using nuclear magnetic resonance, circular dichroism, electron paramagnetic resonance, ultraviolet−visible spectroscopy, potentiometry, and mass spectrometry. We test the influence of Cu 2+ on the aggregation properties of these amylin analogues with thioflavin T assays. We find that both peptides form stable complexes with Cu 2+ with similar affinities at a 1:1 ratio. The N-termini of both peptides are involved in Cu 2+ binding; His18 imidazole is an equally attractive binding site in the case of pramlintide. Our results show that Cu 2+ ions influence the aggregation of pramlintide, but not that of rat amylin. Figure 1. Primary sequence of amylin analogues. Differences among human amylin, rat amylin, and pramlintide primary structures are colored red. Article pubs.acs.org/IC
■ INTRODUCTION
Amylin, islet amyloid polypeptide, and IAPP are all names for a specific 37-amino acid peptide hormone that has an amidated C-terminus and a disulfide bridge between Cys2 and Cys7. This amino acid is secreted from pancreatic β-cells into the bloodstream along with insulin. 1 The effects of amylin are complementary to those of insulin, which is the primary hormone that regulates and maintains blood glucose levels. 2, 3 Insulin was the first peptide hormone discovered and is used successfully to treat diabetic patients. 4−6 Human IAPP (hIAPP) plays a role in glycemic regulation by slowing gastric emptying and promoting satiety, thereby preventing postprandial spikes in blood glucose levels. However, it cannot be used as a drug for diabetic treatment because of its tendency to misfold and form cytotoxic fibrils, 7 which have been strongly associated with β-cell degeneration in type 2 diabetes mellitus (T2DM). 8−10 This limitation led to the development of an amylin synthetic analogue, pramlintide, to overcome the physicochemical properties of aggregation and toxicity. The amino acid sequence of pramlintide is characterized by the substitution of Ala25, Ser28, and Ser29 in the hIAPP sequence with prolines 11 (Figure 1 ), and these substitutions make pramlintide very suitable for use as a drug. 12 Pramlintide is commonly used in the United States in insulin-resistant patients 13 and has also recently been shown to have antimicrobial properties. 14 Rat IAPP (rIAPP) is a nontoxic and nonamyloidogenic peptide variant of human amylin. rIAPP differs from hIAPP in its amino acid sequence in six amino acid residues, having three prolines in the same positions as pramlintide, F23L and I26V substitutions, and, most importantly, an H18R substitution, which eliminates one of the possible strong Cu 2+ binding sites 15 (Figure 1 ).
The metabolism of copper(II) is associated with pathological amyloid formation in diabetes. 16 Previous studies have recognized the importance of the interaction of amylin with Cu 2+ and Zn 2+ ; this interaction is associated with the aggregation of amylin and the modulation of the proteolytic activity of IAPP-degrading enzymes; 17−22 however, there are some conflicting findings about the impact of Cu 2+ on human amylin, related to both increased and decreased copper(II)mediated amylin cytotoxicity. 23−25 The easy release and absorption of one electron in Cu 2+ makes it particularly useful in oxidation−reduction reactions and free radical scavenging. 26−28 At physiological pH (7.4), there is little or no free Cu 2+ in solution, especially if chelating agents are available within its proximity. 21 In the neutral-pH range, Cu 2+ can bind to the rIAPP peptide fragment -19 SSNN 22 -. 29 If the N-terminal amino group is available for binding, it serves as an anchoring site for Cu 2+ . 30 However, even if this group is acetylated, the -19 SSNN 22 -sequence can still form stable complexes with Cu 2+ , where the amide nitrogens are the binding sites, and the asparagine side chains additionally stabilize the square planar Cu 2+ complex. 29, 31 Sanchez-Lopez et al. showed that in several amylin fragments, Cu 2+ binds to the imidazole N1 of His18 and to the deprotonated amides of Ser19 and Ser20, which is, from a thermodynamical point of view, not the most common type of coordination. In such cases, a seven-membered chelate ring is formed instead of the thermodynamically preferred sixmembered ring that would have formed if the amides in the N-terminal direction had participated in binding. 32 The role of His18 in Cu 2+ binding has also been shown in an amylin 1−19 fragment 33 and in an R18H substituted analogue of rat amylin. 34 The lack of His18 in rat amylin makes it not susceptible to aggregation. 15 ■ EXPERIMENTAL SECTION Synthesis. C-Protected disulfide-bridged pramlintide (KCNTA-TCATQRLANFLVHSSNNFGPILPPTNVGSNTY-NH 2 ) and C-protected disulfide-bridged rat amylin (KCNTATCATQRLANFLV-RSSNNLGPVLPPTNVGSNTY-NH 2 ) were purchased from Kare-BayBiochem (certified purity of 99.30%) and used as received. We checked their purity potentiometrically. The Cu(NO 3 ) 2 was an extra pure product (Sigma-Aldrich); we determined the concentrations of their stock solutions by ICP-MS. The carbonate-free stock solution of 0.1 M NaOH was purchased from Merck and then potentiometrically standardized with potassium hydrogen phthalate.
Mass Spectrometry. We obtained high-resolution mass spectra from a BrukerQ-FTMS spectrometer (BrukerDaltonik, Bremen, Germany), equipped with an Apollo II electrospray ionization source with an ion funnel. We operated the mass spectrometer in positive ion mode. We set the instrumental parameters as follows: scan range of m/z 300−3000, dry gas ofnitrogen, temperature of 170°C, and ion energy of 5 eV. The capillary voltage was optimized to the highest signal-to-noise ratio that was observed for a voltage of 4500 V. The small changes in voltage (±500 V) did not significantly affect the optimized spectra. We prepared the samples (1:1 Cu 2+ :ligand stoichiometry, [ligand] tot = 10 −4 M) in a 1:1 acetonitrile/water mixture at pH 7.4. The variation in the solvent composition down to 5% acetonitrile is expected not to change the species composition significantly. We infused the sample at a flow rate of 3 μL/min. We calibrated the instrument externally with the Tunemix mixture (BrukerDaltonik) in the quadratic regression mode. We processed the data using the Bruker Compass DataAnalysis 4.0 program. The mass accuracy for the calibration was better than 5 ppm, enabling, together with the true isotopic pattern (using SigmaFit), an unambiguous confirmation of the elemental composition of the obtained complex.
Potentiometry. We calculated the stability constants for proton and Cu 2+ complexes from titration curves carried out over the pH range of 2−11 at 298 K with an ionic strength of 0.1 M (KNO 3 ) using a total volume of 3 cm 3 . We performed the potentiometric titrations using a Dosimat 665 Metrohm titrator connected to a Metrohm 691 pH-meter and a Mettler Toledo InLab microglass electrode. The thermostabilized glass cell was equipped with a magnetic stirring system, a microburet delivery tube, and an inlet−outlet tube for argon. We titrated the solutions with 0.1 M carbonate-free NaOH. We calibrated the electrodes for hydrogen ion concentration by titrating HNO 3 with NaOH under the same experimental conditions that are described above. We determined the purities and the exact concentrations of the ligand solutions by the Gran method. 35 The ligand concentration was 0.5 mM, and the Cu 2+ :ligand ratio was 1:1.
We used the HYPERQUAD 2006 and SUPERQUAD programs for the stability constant calculations. 36, 37 We computed the standard deviations with HYPERQUAD 2006, which refer to random errors only. We computed the speciation and competition diagrams with the HYSS program. 38 Nuclear Magnetic Resonance (NMR) Spectroscopy. Pramlintide was dissolved in 500 μL of 100% D 2 O, and rIAPP was dissolved in 800 μL of 100% D 2 O, both to a concentration of 1 mM. We manually adjusted the pH electrode readout to 5.10 (which corresponded to pH 5.51 according to Covington et al. 39 ) with a stock solution of 0.1 M NaOD in 100% D 2 O. We used these samples for 1 H and 13 C resonance assignments. We then manually adjusted the pH to 7.4 with a 0.1 M NaOD stock solution in 100% D 2 O and then adjusted the assignments of 1 H and 13 C resonances to the new conditions. To assign HN resonances, we prepared samples of the studied peptides in an analogous way but in a 90:10 (v/v) H 2 O/D 2 O solution, and after assignment, we manually corrected the pH of the solution to 7.4 using the 0.1 M NaOH stock solution in 100% H 2 O. We performed all NMR experiments on the 600 and 700 MHz Bruker spectrometer at 25°C. The NMR data were processed by NMRPipe 40 and analyzed with Sparky 41 software. Analysis of the 1 H, 13 C, and 15 N resonances for the two peptides was carried out by application of a standard procedure 42 based on the inspection of the two-dimensional (2D) homonuclear 1 H− 1 H TOCSY (with mixing times of 10 and 80 ms), 2D 1 H− 1 H ROESY, and 2D 1 H− 1 H NOESY (with mixing times of 300 and 500 ms) supported by the natural abundance 2D 1 H− 15 N HSQC and 2D 1 H− 13 C HSQC experiments (separately tuned for the aliphatic and aromatic regions).
The addition of paramagnetic Cu 2+ to the solution caused signal broadening because of the paramagnetic contribution of Cu 2+ to the spin−lattice relaxation (R 1 ) rates of 1 H protons. 42, 43 To decipher the residues involved in the Cu 2+ coordination for the studied peptides, we monitored the binding of Cu 2+ to the pramlintide and rIAPP peptides by NMR. We performed Cu 2+ measurements through the stepwise addition of a Cu(NO 3 ) 2 stock solution [0.01 M in 100% D 2 O for the samples in 100% D 2 O and in 100% H 2 O for the samples in a 90:10 (v/v) H 2 O/D 2 O mixture] to the solution of peptides, giving peptide:Cu 2+ molar ratios of 1:0.02, 1:0.04, 1:0.08, and 1:0.16. For each peptide:Cu 2+ ratio, we checked the pH and adjusted it to 7.4 (when necessary) with the 0.1 M NaOD stock solution. We recorded the same set of one-dimensional and 2D NMR spectra that were recorded for the free peptides for the complexes with Cu 2+ .
Electron Paramagnetic Resonance (EPR) Spectroscopy. We used EPR spectroscopy to study the paramagnetic transition metals 44−49 and organic radicals. 50−56 Specifically, we utilized EPR spectroscopy to study the interactions between the Cu 2+ ions and amylin analogues, where we measured the g values and the hyperfine coupling values for free ions and the peptide samples as titrated with a Cu 2+ solution. We recorded the EPR spectra using an X-band continuous wave Bruker EMX PLUS spectrometer equipped with a standard resonator for high-sensitivity CW-EPR (Bruker BioSpin, Rheinstetten, Germany). For comparative analysis, we carried out all experiments under the same instrumental parameters. We recorded the spectra at 100 K using the Bruker nitrogen setup. The microwave power was set to 0.625 mW with a 5 G modulation amplitude and a 100 kHz modulation frequency. We used the Bruker Xenon software (Bruker BioSpin) to collect data and for postprocessing.
Ultraviolet−Visible (UV−vis) and Circular Dichroism (CD) Spectroscopy. We recorded the absorption UV−vis spectra on a Varian Cary300 Bio spectrophotometer, in the range of 200−800 nm, Inorganic Chemistry pubs.acs.org/IC Article using a quartz cuvette with an optical path of 1 cm. A Jasco J-1500CD spectrometer recorded the CD spectra in the range of 200−800 nm, using a quartz cuvette with an optical path of 1 cm in the visible and near-UV range. We prepared the Cu 2+ −peptide complexes in a water solution of HNO 3 at an ionic strength of 0.1 mol dm −3 (KNO 3 ). The concentrations of the solutions used for spectroscopic studies were similar to those employed in the potentiometric experiments. The metal:ligand ratio was 1:1. We adjusted the pH with the appropriate amounts of HNO 3 and NaOH solutions. We calculated the UV−vis and CD spectroscopic parameters from the spectra obtained at the pH values corresponding to the maximum concentration of each particular species, based on distribution diagrams. 
■ RESULTS AND DISCUSSION
We studied the Cu 2+ complexes with rat amylin and pramlintide by mass spectrometry, potentiometry, the ThT assay, and UV−vis, CD, NMR, and EPR spectroscopy. The mass spectrometric measurements provided information about the stoichiometry of the formed complexes. We determined the precise stability constants and pH-dependent species distribution diagrams by potentiometric titrations. The spectroscopic results allowed us to deduce the mode of binding of the Cu 2+ complexes formed with the studied peptides and the geometry of the formed species. The NMR spectra recorded in the presence and absence of the metal ions indicated the precise metal binding sites.
Stoichiometry of the Binding of Cu 2+ with Amylin. ESI-MS spectrometry confirmed that both peptides form only mononuclear complexes with copper(II) ions. In the Cu 2+ −rat amylin mass spectra ( Figure S1 ), the prevailing signals correspond to the free ligand (m/z 980.5, z = 4+), its sodium adducts that contain one sodium atmo (m/z 986.0, z = 4+) and two sodium atoms (m/z 991.5, z = 4+), an equimolar copper(II) complex (m/z 996.2, z = 4+), and its sodium adduct (m/z 1001.2, z = 4+). In the case of pramlintide, in the mass spectra ( Figure S2 ), we can observe signals that can be assigned to the free ligand (m/z 988.0, z = 4+), the dehydrated ligand (m/z 982.5, z = 4+), adducts with sodium (m/z 992.0, z = 4+) and potassium (m/z 997.7, z = 4+) atoms, the copper(II) complex (m/z 1003.2, z = 4+), and its sodium (m/ z 1009.0, z = 4+) and potassium adducts (m/z 1012.9, z = 4+). In both cases, the simulated isotopic patterns of copper(II) complexes are in a perfect agreement with the experimental ones.
Protonation Equilibria. Rat amylin (KCNTATCAT-QRLANFLVRSSNNLGPVLPPTNVGSNTY-NH 2 ) behaves as an LH 3 acid, with the deprotonating groups corresponding to the N-terminal amine group, tyrosine side chain, and lysine side chain with pK a values of 7.13, 9.49, and 10.20, respectively ( Table 1 ). The cysteine groups are bridged with a disulfide bond, and the C-terminal tyrosine is amidated, as in wild type rat amylin. We previously discussed protonation constants of pramlintide (KCNTATCATQRLANFLVHSSNNFGPILPP-TNVGSNTY-NH 2 ), 60 showing that it behaves as an LH 4 acid, with the deprotonating groups corresponding to the histidine imidazole, the N-terminal amine group, and the tyrosine and lysine side chain groups, with pK a values of 5.79, 7.53, 9.67, and 10.32, respectively.
Cu 2+ −rIAPP Complex. The coordination of Cu 2+ with rat amylin begins at pH 4 (Figure 2A ). The maximum of the CuHL form occurs around pH 5.5, with the N-terminal amine group and the closest amide involved in coordination, resulting in a pronounced CT band near 290 nm and a d−d transition at 588 nm in the CD spectra, respectively ( Figure S3 ). The spectra indicate that the complex starts to adopt a square planar geometry, with the amide nitrogen being involved in the coordination. The CD band near 278 nm suggests that the Nterminal amine takes part in the binding. The next two deprotonations lead to the formation of the CuL and CuH −1 L forms, with pK a values of 8.08 and 9.44, respectively. Because we observe a blue shift and an increase in intensity in CD [from 588 to 566 nm (Table 1 and Figure S3 )] and UV−vis [from 557 to 542 nm (Table 1 and Figure S4 )], we can assume that two more amides are involved in coordination, resulting in an (NH 2 , 3N am ) binding mode (Figure 3 ). Further support comes from EPR data. Both g ∥ and the hyperfine coupling constant parameter (A ∥ ), which equal 2.22 and 198 G, respectively (Table 1) , indicate a 3N coordination mode for CuL species and a 4N coordination mode for CuH −1 L, with a g ∥ of 2.26 and an A ∥ of 194. We also must take into account the fact that the CuLH −1 species may involve not only a pure amide coordination but also a partial deprotonation of the noncoordinating tyrosine chain, as indicated by a quite high wavelength at which a UV−vis maximum for these species is observed [542 nm instead of a typical value of 520 nm; a The errors in EPR parameters were estimated to be ±0.0002.
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pubs.acs.org/IC Article D similar phenomenon could also be possible in the Cu(II)− pramlintide species discussed below]. In the CuL species, at pH 7.4, on the NMR spectra, almost all residues are evenly and very weakly affected, with the exception of three of the initial residues, Lys1, Cys2, and Asn3, and two latter residues, Leu16 and Val17, whose intensity decreases to ∼80% of their initial value after the addition of 0.08 equiv of Cu 2+ (Figure 4A ). The two remaining deprotonations (pK a s of 9.44 and 9.76) lead to CuH −2 L and CuH −3 L forms and are related to the deprotonation of the unbound tyrosine and lysine side chains and do not change the coordination sphere.
Cu 2+ −Pramlintide Complex. The coordination of Cu 2+ to pramlintide begins around pH 4 ( Figure 2B ). In the CuH 2 L complex form, the His18 imidazole and the N-terminal amine groups are involved in the coordination sphere, resulting in an [N im , NH 2 ] type of coordination. His18 is directly involved in the binding, which is proven by the prominent intensity decrease and the signal broadening of the imidazole ring signals of His18 determined by NMR. Also at pH 5.5, immediately after the dissolution of the peptide and the addition of Cu 2+ , we observe signal broadening in the N- Figure S5) . The loss of one proton leads to the formation of the CuHL complex, with a maximum at pH 6, in which a d−d transition band at ∼610 nm starts to appear on the CD spectra ( Figure  S6 ) and the band near 564 nm is visible in the UV−vis spectra ( Figure S7 ). These spectroscopic results suggest that the amide group is engaged in coordination at this pH. The next two deprotonations lead to the formation of CuL and CuH −1 L complexes. We observe a significant blue shift in the CD (from 610 to 599 nm and then to 564 nm) and in the UV−vis spectra (from 564 to 558 nm and then to 541 nm) ( Figures S6 and  S7) . These shifts indicate the participation of two more amide nitrogens in the metal coordination. At this point, the CD spectra of the Cu 2+ −pramlintide complex are very similar to those of the Cu 2+ −rat amylin complex ( Figures S3 and S6 ). EPR parameters [g ∥ = 2.217 and A ∥ = 192 G for CuL species, and g ∥ = 2.20 and A ∥ = 195 G for CuH −1 L ( Table 1) ] are indicative of the involvement of three and four nitrogen atoms in the coordination sphere. Most likely, an equilibrium between two Cu 2+ −pramlintide forms is reached: the first form, in which the N-terminal amine and the adjacent amides are bound to Cu 2+ [because in the NMR spectra, at pH 7.4, we observe a signal broadening of N-terminal residues, especially in the Cα region of Lys1, Cys2, and Asn3 in the 1 H− 13 C HSQC spectrum ( Figure 4B) ], and the second, in which the His18 imidazole and the preceding amides are involved in the binding [because also the signal broadening in the Cα region of Val17 and Leu16 is observed in the NMR spectra, at pH 7.4 ( Figure 4B) ]. Both of the proposed Cu 2+ coordination modes are presented at Figure 5 . The loss of two additional protons (pK a s of 9.59 and 10.14) at a very basic pH is associated with the deprotonation of tyrosine and lysine and has no impact on the coordination mode.
The constant exchange between Cu 2+ and the peptides is indicated by the decrease in the signal intensity of the Cα-Hα peaks for residues such as Ala5−Ala8 and Thr30−Thr36 for pramlintide (and also Thr6−Ala8 and Ser29−Thr36 for rIAPP), which are neither directly involved in permanent Cu 2+ binding nor located in the sequential proximity of the residues involved in Cu 2+ coordination (Figure 4 ). The observed decrease in cross-peak intensity for the residues mentioned above can be attributed to these regions being in the spatial proximity to the mentioned sites and the Cu 2+ ions being in constant exchange between the peptide molecules that are in quantitative excess.
Effect of Cu 2+ on the Aggregation Kinetics of Amylin Analogues. We evaluated the aggregation of pramlintide and rat amylin in the presence and absence of Cu 2+ ions to examine the effect of Cu 2+ on the two peptides ( Figure 6 ). We carried out the tests in HEPES buffer at pH 7.4, monitored by ThT fluorescence. Using hIAPP as a positive control, which is known for its fast aggregation propensity, 58, 61 we observed that both pramlintide and rIAPP aggregate weakly, as expected, 15, 62, 63 due to the presence of the three proline residues in their primary sequence. 15, 64 Pramlintide aggregation is slightly attenuated by Cu 2+ , which confirms that Cu 2+ changes the globular structure of the peptide. Analogous observations Inorganic Chemistry pubs.acs.org/IC Article have been reported for Cu 2+ binding to a monomeric fragment of hIAPP (15−22) , 64 but a contrary phenomenon was observed for Zn 2+ −pramlintide complexes, where the addition of metal strongly enhanced the precipitation. 59 This was hypothesized to be caused by the formation of a macrochelate, involving His18 imidazole and the N-terminal amine in coordination. In the case of Cu 2+ , its binding either to the N-terminus or to His18 prevents the complex from aggregating. No influence of Cu 2+ on rat amylin aggregation was detected, which leaves us with the conclusion that the binding of Cu 2+ to the imidazole ring decreases the rate of aggregation to pramlintide with respect to rIAPP, most likely due to the fact that binding of Cu 2+ to the imidazole of His18 interrupts β-sheet formation, which is a crucial step for the initiation of the aggregation process.
In summary, the addition of copper(II) ions to pramlintide, the analogue of human amylin, prevents its aggregation, while the addition of this metal to rat amylin has no influence on its aggregation properties. Both peptides bind Cu(II) via the Nterminal amino group and the adjacent amide nitrogens; the major difference in the Cu(II) binding mode comes from the absence of His18 in the sequence of rat amylin, thus preventing the formation of the Cu(II)−His18 bound form, observed in the case of the pramlintide complex. Moreover, Sinopoli et al. showed that the presence of copper(II) not only influences the aggregation properties of amylin analogues but also has a major influence on their cytotoxicity and their vulnerability to being degraded by proteases. 65 Because the dyshomeostasis of Cu(II) seems to be involved in the development of type II diabetes, 16 the differences in the aggregation properties of the two copper(II) complexes may have important implications in vivo. To make this picture even more complicated, one has to keep in mind the findings of Tomasello et al., who showed that the rat amylin-mediated β-cell toxicity can occur despite the absence of any amyloid forms. 66 Further work, in collaboration with a group of biologists, is underway in our group.
■ CONCLUSIONS
The interactions of the studied amylin analogues, rat amylin and pramlintide, with Cu 2+ result in conformational changes in these analogues. Certain differences in the primary sequence of these molecules affect the mode of coordination of these peptides with Cu 2+ . Rat amylin and pramlintide form stable and monomeric complexes with this metal, as proven by MS, NMR, CD, EPR, and UV−vis spectroscopies and potentiometric titrations. To the best of our knowledge, this is the first detailed study of this chemical phenomenon using this many different analytical methods. In both cases, the N-terminus of the peptides is directly involved in Cu 2+ binding in solution (Figures 3 and 4 ). However, in the case of pramlintide, two species coexist together in solution: the one in which copper(II) is bound to the N-terminus and neighboring amides and the other in which the imidazole ring of His18 and neighboring amides directed toward the N-terminus are also involved in Cu 2+ binding ( Figure 5 ). Differences in the stabilities of Cu 2+ −rat amylin and Cu 2+ −pramlintide complexes are minor (as visualized by a competition plot in Figure  S8 ).
These findings are in very good agreement with previously published data for a mutated R18H Cu 2+ −rat amylin complex 33 and with the results of studies of the hIAPP1−19 fragment bound to Cu 2+ . 60 Pramlintide aggregation is slightly attenuated by Cu 2+ , which confirms the impact of this metal on the globular structure of the peptide. Because no influence of Cu 2+ on rat amylin aggregation was detected, we may hypothesize that the binding of Cu 2+ to the imidazole ring decreases the rate of aggregation to pramlintide with respect to that of rat amylin. Most probably, the coordination of Cu 2+ to His18 imidazole interrupts β-sheet formation, which is one of the first steps of aggregation.
The findings outlined in this study on the coordination of Cu 2+ with weakly aggregating analogues of amylin on the atomic level broaden our understanding of the behavior of amylin in terms of its structural properties in solution and aggregation properties upon interaction with the biologically relevant Cu 2+ ion. 
